REFERENCES
- Rintala E. Incidence and clinical significance of positive blood cultures in febrile episodes of patients with hematological malignancies. Scand J Infect Dis 1994; 26: 77–84.
- Bodey GP, Buckley M, Sathe YS, Freiriech EJ. Quantitative relationships between circulating leukocytes and infection in patients with acute leukemia. Ann Intern Med 1966; 64: 328–40.
- Bostrom B, Weisdorf D. Mucositis and alpha-streptococcal sepsis in bone marrow transplant recipients. Lancet 1984; 1: 1120–1.
- González-Barca E, Fernández-Sevilla A, Carratalá A, Grañena A, Gudiol F. Prospective study of 288 episodes of bacteremia in neutropenic cancer patients in a single institution. Eur J Clin Microbiol Infect Dis 1996; 15: 291–6.
- Estling LS, Bodey GP, Keefe BH. Septicemia and shock syndrome due to viridans Streptococci: a case-control study of predisposing factors. Clin Infect Dis 1992; 14: 1201–7.
- Fredlund H, Björeman M, Kjellander J, Sjöberg L, Bjorne L, Öhlin A-L. A 10-year survey of clinically significant blood culture isolates and antibiotic susceptibilities from adult pa tients with hematological diseases at a major Swedish hospital. Scand J Infect Dis 1990; 22: 381–91.
- Engervall P, Stiernstedt G, Günther GC, Björkholm M. Trimethoprim-sulfamethoxazole plus amikacin as first empiri cal therapy and imipenem/cilastatin as secondary therapy in febrile neutropenic patients with hematological disorders. J Chemother 1992; 4: 99–106.
- Bodey GP, Jadeja L, Elting L. Pseudomonas bacteremia: retrospective analysis of 410 episodes. Arch Intern Med 1985; 145: 1621–9.
- Bodey GP, Elting L, Kassamali H, Lim BP. Escherichia coli bacteremia in cancer patients. Am J Med 1986; 81: 85–95.
- Rubio M, Palau L, Romero Vivas J, del Porto E, Diaz-Mediavilla J, Alvarez A, Martinez R, Picazo JJ. Predominance of Gram-positive microorganisms as a cause of septicemia in patients with hematological malignancies. Infect Control Hosp Epidemiol 1994; 15: 101–4.
- Johansson H, Sternby E, Ursing B. Septicemia in granulocy topenic patients: a shift in bacterial etiology. Scand J Infect Dis 1992; 24: 357–60.
- Cruciani M, Rampazzo R, Malena M, Lazzarini L, Todeschini G, Messori A, Concia E. Prophylaxis with fluoroquinolones for bacterial infections in neutropenic pa tients: a meta-analysis. Clin Infect Dis 1996; 23: 795–805.
- Engels E, Lau J, Baraza M. Ef cacy of quinonlone prophy laxis in neutropenic cancer patients: a meta-analysis. J Clin Oncol 1998; 16: 1179–87.
- Dwyer R, Ringertz S. Viridans streptococci in blood cultures. Can we see any patterns of species related to patient category? APMIS 1997; 105: 972–4.
- Bochud P-Y, Calandra T, Francioli P. Bacteremia due to viridans streptococci in neutropenic patients: a review. Am J Med 1994; 97: 256–64.
- Classen D, Burke J, Ford C, Evershed S, Aloia M, Wilfahrt J, Elliott J. Streptococcus mitis sepsis in bone marrow transplant patients receiving oral antimicrobial prophylaxis. Am J Med 1990; 89: 441–6.
- Kern W, Kurrle E, Schmeiser T. Streptococcal bacteremia in adult patients with leukemia undergoing aggressive chemotherapy: a review of 55 cases. Infection 1990; 18: 138–45.
- Bouchud P-Y, Eggiman Ph, Calandra TH, Van Melle G, Saghafi L, Francioli P. Bacteremia due to viridans Streptococ cus in neutropenic patients with cancer: clinic spectrum and risk factors. Clin Infect Dis 1994; 18: 25–31.
- Spanik S, Trupl J, Kunova A, Botek R, Sorkovska D, Grey E, Studena M, Lacka J, Oravcova E, Krchnakova A, Rus-nakova V, Svec J, Krupova I, Grausaova S, Stopkova K, Koren P, Krcmery V. Viridans streptococcal bacteraemia due to penicillin-resistant and penicillin-sensitive streptococci: analysis of risk factors and outcome in 60 patients from a single cancer centre before and after penicillin is used for prophylaxis. Scand J Infect Dis 1997; 29: 245–9.
- Bow E, Lionel A, Mandell L, Louie T, Feld R, Palmer M, Zee B, Pater J. Quinolone-based antibacterial chemoprophy laxis in neutropenic patients: effect of augmented Gram-posi tive activity on infectious morbidity. Ann Intern Med 1996; 125: 183–90.
- Maschmeyer G, Hiddemann W, Link H, Cornely OA, Buch heidt D, Glaß B, Adam D. Management of infections during intensive treatment of hematologic malignancies. Ann Hematol 1997; 75: 9–16.
- Wilhelm M, Kantarjian HM, O’Brien S, Pierce S, Keating MJ, Freireich EJ, Estey EH. Pneumonia during remission induction chemotherapy in patients with AML or MDS. Leukemia 1996; 10: 1870–3.
- Ewig S, Glasmacher A, Ulrich B, Wilhelm K, Schäfer H, Nachtsheim K-H. Pulmonary infiltrates in neutropenic pa tients with acute leukemia during chemotherapy: outcome and prognostic factors. Chest 1998; 114: 444–51.